-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Peptides can be used to solve the thorny problem of human antibiotic resistance
The Rice laboratory of chemist Anatoly Kolomeisky simulated a series of antimicrobial peptides (AMPs) that help natural and diverse molecules in biological systems to evaluate the mechanisms they use to stop harmful bacteria
amp kills bacteria in two steps: first attaches to the cell membrane of the bacteria, and then inhibits the bacteria
According to their calculations, the invasion seems to depend on a large number of peptides-even millions of peptides-entering the bacteria, but the peptides needed to inhibit the bacteria from the inside may be much less, because the bacteria are particularly good at sticking gears inside
"AMP can inhibit bacteria in many ways," said Kolomeiski, a professor of chemistry
The research was published in "Interface.
Understanding the mechanism of peptides requires the establishment of a theoretical framework to test the speed at which different AMP populations can remove bacteria from the system
The results are consistent with the experimental data and help explain how and why amps show effectiveness in a wide range of concentrations
With the presence of more types of amps, peptides are better at entering and dividing cells
Teimouri said: "The high heterogeneity of the absorbed amp amount corresponds to the fast-entering peptides, while the low heterogeneity describes the fast-killing peptides
The researchers hope that their model can help others design therapeutic antimicrobial peptides that succeed where antibiotics fail, especially by adjusting their ability to enter the target bacteria
Original search:
DOI
10.
Single-cell stochastic modelling of the action of antimicrobial peptides on bacteria